We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

LifeArc Announces £5M Support for Rare Disease Research

News   Mar 02, 2018 | Priginal story from LifeArc

 
LifeArc Announces £5M Support for Rare Disease Research
 
 
 

RELATED ARTICLES

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

How Does DEET Keep Mosquitoes at Bay?

News

Since its invention during WWII, researchers have been trying to pinpoint precisely how DEET actually affects mosquitos. New research suggests DEET may chemically “cloak” humans from malaria-carrying mosquitos, rather than repel them.

READ MORE

Drug Treats Inflammation Related to Genetic Heart Disease

News

Johns Hopkins researchers have shed new light on the role of the immune system in the progression of arrhythmogenic cardiomyopathy (ACM) and have also discovered a drug that may help prevent ACM symptoms and progression to heart failure.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE